You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.
Medtronic raises fiscal Q3'20 cash dividend by 8%
Gauging Supply Chain Risk In Volatile Times
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help
The Market Intelligence Platform
Medtronic PLC's board approved a dividend of 54 cents per ordinary share for the third quarter of the fiscal year 2020.
The dividend is 8% higher than the prior-year period and is payable Jan. 17, 2020, to shareholders of record as of Dec. 27.
Dublin-based Medtronic sells device-based medical treatments focused on cardiovascular disease, regenerative therapies and diabetes to hospitals and physicians.